Country-Specific Approaches to Preventing Infections in Cataract Surgery
Authors:
- Mario Damiano ToroMario Damiano Toro
- Alina Popa-CherecheanuAPAlina Popa-Cherecheanu
- Nora MajtanovaNMNora Majtanova
- Štěpán RusňákŠRŠtěpán Rusňák
- Nikoloz LabauriNLNikoloz Labauri
- Vladimir PfieferVPVladimir Pfiefer
- Nikolai DakovNDNikolai Dakov
- Gábor NémethGNGábor Németh
- Vahe NanyanVNVahe Nanyan
- Izabela Korona-GłowniakIzabela Korona-Głowniak
- Robert RejdakRobert Rejdak
Open Access
- 23 November 2025
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 14 (12) , 1192
Abstract
Background/Objectives: Antimicrobial resistance (AMR) is a major global health threat. In patients undergoing cataract surgery, AMR complicates infection control, particularly efforts to reduce the risk of endophthalmitis—a rare but severe postoperative complication. This article reviews country-specific strategies for endophthalmitis prevention, focusing on antimicrobial use. Methods: Ophthalmology experts from 10 countries contributed national perspectives on infection prevention. Official guidelines served as the primary basis for analysis; when unavailable, expert opinion and routine clinical practice were considered. Results: Routine preoperative antibiotic use is uncommon in 6 out of 10 countries. Instead, artificial tears and bacteriostatic or bactericidal treatments are frequently employed. One country allows optional antibiotic use, while 3 include it in routine preoperative care. For intraoperative management, antisepsis with 5–10% povidone-iodine is standard practice in 9 countries. Intracameral cefuroxime (typically 1 mg/0.1 mL) is widely used in 7 countries and considered essential in most countries. Postoperatively, broad-spectrum topical antibiotics, primarily fluoroquinolones, are typically prescribed, often as fixed-dose combinations with corticosteroids (8 countries), although duration and regimens vary. Conclusions: Despite national differences, povidone-iodine, intracameral cefuroxime, and topical fluoroquinolones are widely used. Preoperative antibiotic use varies, while postoperative regimens are more consistent. These practices reflect local AMR patterns, regulations, and available healthcare resources. Although broad-spectrum agents are generally preferred, they raise concerns about resistance. Tailoring prophylactic strategies to local microbiological profiles and limiting the duration of antibiotic therapy are key to balancing efficacy and stewardship. An individualized, evidence-based approach is essential to reduce endophthalmitis risk and address AMR challenges.Keywords
Funding Information
- Santen
This publication has 62 references indexed in Scilit:
- CataractsJAMA, 2025
- High risk and low prevalence diseases: EndophthalmitisThe American Journal of Emergency Medicine, 2023
- Cost-Effectiveness of Preoperative Topical Antibiotic Prophylaxis for Endophthalmitis Following Cataract SurgeryAmerican Journal of Ophthalmology, 2022
- Analysis of antibiotic resistance and genetic profile of conjunctival bacteria flora before and after cataract surgeryInternational Ophthalmology, 2022
- Recent advances in intraocular sustained-release drug delivery devicesDrug Discovery Today, 2019
- Ocular Flora and Their Antibiotic Resistance Patterns in the Midwest: A Prospective Study of Patients Undergoing Cataract SurgeryAmerican Journal of Ophthalmology, 2013
- Epidemiology of postoperative endophthalmitis in an Asian population: 11-year incidence and effect of intracameral antibiotic agentsJournal of Cataract & Refractive Surgery, 2012
- Antibiotics in the aquatic environment – A review – Part IChemosphere, 2009
- A Randomized, Masked Comparison of Topical Ketorolac 0.4% Plus Steroid vs Steroid Alone in Low-Risk Cataract Surgery PatientsAmerican Journal of Ophthalmology, 2008
- Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factorsJournal of Cataract & Refractive Surgery, 2007